Double Trouble for Cancer Tumors

Cancer immunotherapy drugs called PD-1 inhibitors are widely used to stimulate the immune system to fight cancer, but many patients either don’t respond or develop resistance to them. A new small-molecule drug candidate being tested in an early-stage clinical trial aims to improve patient responses to immunotherapy. Check the paper in Nature.

Previous post
New cancer-killing pill annihilates tumors